Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfeffer

Showing results (441-450 of 908) with videos related to

Pageof 91
Sort By:
Circulation|June 26, 2002
Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research studyGary F Mitchell, Joseph L Izzo, Yves Lacourcière, et al.
American Heart Journal|June 7, 2011
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarctionAnil Verma, Marc A Pfeffer, Hicham Skali, et al.
The American Journal of Cardiology|August 15, 1997
Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarctionS C Greaves, G Zhi, R T Lee, et al.
Dementia and Geriatric Cognitive Disorders|November 2, 2002
Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotypeT Gabryelewicz, D Religa, M Styczynska, et al.
Plos One|July 26, 2019
Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan AfricaPaul Roddy, Ursula Dalrymple, Tomas O Jensen, et al.
The American Journal of Cardiology|September 5, 2006
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trialJames A de Lemos, Stephen D Wiviott, Sabina A Murphy, et al.
Journal of the American College of Cardiology|May 16, 2006
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programLars G Olsson, Karl Swedberg, Anique Ducharme, et al.
Circulation. Cardiovascular Quality and Outcomes|March 18, 2010
Cognitive function and anticoagulation control in patients with atrial fibrillationGreg C Flaker, Janice Pogue, Salim Yusuf, et al.
Lancet (London, England)|December 13, 2005
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialBradi B Granger, Karl Swedberg, Inger Ekman, et al.
Pediatric Research|April 24, 2026
Stretch, Piezo channels, and store operated calcium entry in developing human airway smooth muscleDaniel A Pfeffer-Kleemann, Michael A Thompson, Niyati A Borkar, et al.
Pageof 91

Showing results (441-450 of 908) with videos related to

Sort By:
Pageof 91
Circulation|June 26, 2002
Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research studyGary F Mitchell, Joseph L Izzo, Yves Lacourcière, et al.
American Heart Journal|June 7, 2011
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarctionAnil Verma, Marc A Pfeffer, Hicham Skali, et al.
The American Journal of Cardiology|August 15, 1997
Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarctionS C Greaves, G Zhi, R T Lee, et al.
Dementia and Geriatric Cognitive Disorders|November 2, 2002
Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotypeT Gabryelewicz, D Religa, M Styczynska, et al.
Plos One|July 26, 2019
Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan AfricaPaul Roddy, Ursula Dalrymple, Tomas O Jensen, et al.
The American Journal of Cardiology|September 5, 2006
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trialJames A de Lemos, Stephen D Wiviott, Sabina A Murphy, et al.
Journal of the American College of Cardiology|May 16, 2006
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programLars G Olsson, Karl Swedberg, Anique Ducharme, et al.
Circulation. Cardiovascular Quality and Outcomes|March 18, 2010
Cognitive function and anticoagulation control in patients with atrial fibrillationGreg C Flaker, Janice Pogue, Salim Yusuf, et al.
Lancet (London, England)|December 13, 2005
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trialBradi B Granger, Karl Swedberg, Inger Ekman, et al.
Pediatric Research|April 24, 2026
Stretch, Piezo channels, and store operated calcium entry in developing human airway smooth muscleDaniel A Pfeffer-Kleemann, Michael A Thompson, Niyati A Borkar, et al.
Pageof 91